Akiyama, N., Karayama, M., Iwaizumi, M., Kusama, Y., Kono, M., Hozumi, H., . . . Suda, T. (2017). Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine. Intern Med.
シカゴスタイル引用形Akiyama, Norimichi, et al. "Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated With Erlotinib and Oral Fluoropyrimidine." Intern Med 2017.
MLA引用形式Akiyama, Norimichi, et al. "Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated With Erlotinib and Oral Fluoropyrimidine." Intern Med 2017.
警告: この引用は必ずしも正確ではありません.